Most Popular in:
New in Regulatory (page 8 of 13)
Apr 04, 2011 | 01:33 PM CDT
The U.S. Food and Drug Administration (FDA) has sent a message to consumers requesting them to notify it of all adverse reactions to beauty, personal hygiene and color cosmetic products.
Mar 08, 2011 | 11:26 AM CST
By: Steve Herman
Common sense and good science are far superior to ill-informed and emotional attacks, and taking the narrative to exposure rather than risk is essential to win consumer confidence.
Nov 18, 2010 | 12:03 PM CST
By: Jeff Falk
The movements, trends and forces that continue to shape the industry.
Nov 05, 2010 | 09:47 AM CDT
By: Steve Herman
The safety of fragrance is under fire from special interests. Understanding where challenges originate and the nature of the message of these challenges will allow better-informed decisions about a fragrance brand or fragranced product.
Jul 16, 2010 | 10:06 AM CDT
The Personal Care Products Council has effected an initiative through which the U.S. Food and Drug Administration (FDA) would have a greater role in assessing ingredient safety for personal care products sold in the United States.
Jun 15, 2010 | 09:33 AM CDT
Fabio Franchina has been elected to a two-year term as president of Colipa, the European Cosmetics Association. The association also has named two vice presidents and a vice president treasurer.
Apr 19, 2010 | 02:33 PM CDT
By: Marie Alice Dibon
The exploding growth of naturals has left many companies and brands looking for a solid base from which to develop their products, and European brands and regulatory bodies are building portfolios with eco-friendliness in mind.
Apr 12, 2010 | 04:35 PM CDT
Workshop to cover latest regulations governing the beauty industry, and will include Q&A sessions.
Mar 05, 2010 | 10:13 AM CST
On March 1, 2010, Colorado's House Committee on Judiciary voted to indefinitely postpone House Bill 10-1248 (HB 1248), or the Colorado Safe Personal Care Products Act.
Feb 23, 2010 | 01:30 PM CST
Bill would prohibit the sale of personal care products formulated with chemicals identified as causing cancer or reproductive toxicity.